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Dysregulation of the complement system has been implicated in the pathogenesis of age-related macular
degeneration. To investigate consequences of altered complement regulation in the eye with age, we
examined Cd59a complement regulator deﬁcient (Cd59a/) mice between 4 and 15 months. In vivo
imaging revealed an increased age-related accumulation of autoﬂuorescent spots in Cd59a/ mice, a
feature that reﬂects accumulation of subretinal macrophages and/or microglia. Despite this activation of
myeloid cells in the eye, Cd59a/ mice showed normal retinal histology and function as well as normal
choroidal microvasculature. With age, they revealed increased expression of activators of the alternative
complement pathway (C3, Cfb, Cfd), in particular in the retinal pigment epithelium (RPE)-choroid but less
in the retina. This molecular response was not altered by moderately-enhanced light exposure. Cd59a
deﬁciency therefore leads to a preferential age-related dysregulation of the complement system in the
RPE-choroid, that alone or in combination with light as a trigger, is not sufﬁcient to cause choroidal
vascular changes or retinal degeneration and dysfunction. This data emphasizes the particular vulnerability
of the RPE-choroidal complex to dysregulation of the alternative complement pathway during aging.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Data from immunohistochemical studies and genome-wide as-
sociation studies have supported the hypothesis that dysregulation
of the complement system plays a major role in the development of
age-related macular degeneration (AMD), the most common cause
of blindness in the western world (Lim et al., 2012). Postmortem
analysis have shown that complement factors and other proin-
ﬂammatory substrates are a main component of drusen, the hall-
mark feature of AMD (Hageman et al., 2001). Further support for an
important role of the complement system in AMD came from the
identiﬁcation of several polymorphisms in genes of the comple-
ment pathway that modify disease risk (for a review on AMD, see
Lim et al., 2012). In particular, the alternative complement pathway
seems to be involved with a polymorphism in the complements, UCL Institute of Ophthal-
3; fax:þ44 (0) 207 608 6903.
ann).
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Inc. This is an open access article ufactor H (CFH)-gene (Y402H), harboring a major risk for the
development of AMD (Klein et al., 2005). The activation of the
alternative complement pathway is not dependent on activation via
antibody fragments or lectin but is instead the consequence of the
balance between constant autoactivation and tight control through
regulators of the complement system such as CFH, CD55, CFI, or
CD59 (Lim et al., 2012; Zipfel and Skerka, 2009). Most complement
proteins of the ﬂuid phase are produced by the liver and distributed
in the plasma, underlining the role of complement as a systemic
player in immunology. However, more evidence is evolving that the
local role, especially of long-term activation in organs with a
distinct immunity and barriers such as brain and eye plays an
important role. It is known that the retinal pigment epithelium
(RPE) and neurosensory retina do express complement factors and
that the expression increases with age (Chen H. et al., 2008, Chen
et al., 2008, 2010; Hageman et al., 2001; Luo et al., 2011). In the
last years, several clinical trials which aim to modify complement
activation in the eye by intravitreal or systemic delivery of mono-
clonal antibodies have been launched (Charbel Issa et al., 2011; Lim
et al., 2012) that target, for example, the alternative complement
pathway by inhibiting complement factor D (CFD) (Lampalizumab,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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complement pathway by inhibiting C5 and interfering with
membrane-attack complex formation similar to but upstream
of CD59 (Eculizumab, Alexion Pharmaceuticals, NCT00935883)
(Yehoshua et al., 2014).
Aging, the biggest risk factor for AMD, causes structural changes
which require adaptive responses of the tissue. These responses
might lead to chronic low-level inﬂammation, and thus, further
upregulation of local cytokine and complement gene or factor
expression, increased macrophage accumulation, and structural
changes of the extracellular matrix, a process often referred to as
parainﬂammation that might also play an important role in the
development of AMD (Hageman et al., 2001; Xu et al., 2009). Why
AMD, a slow disease that progresses over life time, is so strongly
deﬁned by polymorphisms in the innate immune system, a system
that has been historically linked with a very fast and direct acti-
vation, and why those changes increase disease risk in the eye,
remains currently unresolved but might be linked to the particular
characteristics of the eye.
CD59, also calledmembrane inhibitor of reactive lysis or protectin,
is a glycosylphosphatidylinositol (GPI) anchored membrane-bound
protein (Kieffer et al., 1994) that protects host tissue by blocking the
assembly of the membrane-attack complex through binding to C9,
thus inhibiting its integration into the C5b-9 complex (Lachmann,
1991). In human, it is widely expressed on cells of all tissues (Meri
et al., 1991). CD59 has been implicated in paroxysmal nocturnal he-
moglobinuria, a rare clonal hematopoietic stemcell disorder that leads
to complement-mediated lysis of erythrocytes and release of hemo-
globin into the urine. Somatic mutations in the X-linked PIGA gene
(Xp22.1) lead to an insufﬁcient GPI synthesis and thus to an absence of
GPI-anchored proteins such as decay-accelerating factor (CD55) and
CD59 on the clonally-derived cells (Brodsky, 2006). Interestingly,
recent studies have also found a decreased local expression of CD59 in
the RPE of AMD donor eyes compared with age-matched controls,
suggesting a reduced local complement regulation at the level of the
RPE in AMD (Ebrahimi et al., 2013).
In mice, the small (20 kDa) Cd59 protein is expressed in 2
isoforms (Qian et al., 2000). Although mouse Cd59a is known to be
the human ortholog, Cd59b is predominantly expressed in testis and
its knockout leads to increasing male infertility (Donev et al., 2008).
Cd59a is strongly expressed in the neurosensory retina and to a
lesser extent in RPE (Faber et al., 2012), and expression in themouse
eyecup is stronger than in nonocular tissue (Yang et al., 2009).
In vitro experiments on primary human RPE cells showed expres-
sion of complement regulators such as CD59 and their upregulation
as a response to inﬂammatory cytokines (Yang et al., 2009).
To understand the function of CD59, knockout mice have been
used in many disease models. Deﬁciency of Cd59a in mice has been
shown to worsen experimental autoimmune myasthenia (Morgan
et al., 2006), Wallerian degeneration (Ramaglia et al., 2009), neu-
ral tau pathology, and neural degeneration (Britschgi et al., 2012). It
has been linked to exacerbation of systemic autoimmunity (Miwa
et al., 2012) and increased focal cerebral ischemia (Harhausen
et al., 2010). In the eye, Cd59a/ mice developed choroidal neo-
vascularization (CNV) earlier after laser injury and showed
increased membrane-attack complex deposition (Bora et al., 2007).
Furthermore, a soluble CD59 has been shown to attenuate CNV
in the laser-induced CNV mouse model (Cashman et al., 2011).
Cd59a/ mice have also been described as having spontaneous
intravascular hemolysis and hemoglobinuria (Holt et al., 2001), but
overall, their phenotype is considered rather mild and modifying of
other diseases that have an inﬂammatory component.
In this study, we aim to understand the role of the Cd59a
complement regulator for the maintenance of the ocular-immune
homeostasis during aging and how dysregulation of thecomplement system by its genetic ablationmay contribute to ocular
pathology with age. We found that, Cd59a deﬁciency leads to an
increased age-related accumulation of microglia and/or macro-
phages in the subretinal space and to a preferential dysregulation of
the complement system in the RPE-choroid compared with the
neuroretina indicating a shift in innate immune homeostasis with
age. However, alone or in combinations with moderate light
exposure as an additional trigger, Cd59a deﬁciency was not
sufﬁcient to cause vascular changes in the choroid or retinal
degeneration and dysfunction. Nevertheless, this data emphasizes
the preferential susceptibility of the RPE-choroidal complex to
molecular consequences induced by aging and the dysregulation of
the alternative complement pathway.
2. Material and methods
2.1. Animal procedures
We used Cd59a knockout (Cd59a/) mice which were kindly
provided by Professor Paul Morgan from Cardiff University where
they were produced and backcrossed over >8 generations on a
C57BL/6J background (Holt et al., 2001). We backcrossed the
homozygous line to C57BL/6J (Harlan UK Ltd, Blackthorn, UK) mice
over 1 additional generation to generate a heterozygote stock that
was used to generate Cd59a/ and wild-type (WT) littermate
controls. All mice were genotyped for Cd59a and all breeding
pairs were further conﬁrmed as rd8 (Crb1 rd8/rd8) mutation free
(Luhmann et al., 2012). All animals were kept in the same animal
room and 12-hour light-dark cycles [33  28 lux inside the cage
(Luhmann et al., 2013)] with food and water available ad libitum.
For light exposure experiments, mice were moved into a fully
ventilated light exposure rack (in house construction). Illumination
was controlled by integrated light meters at animal level within the
cage. The mice had food and water available ad libitum. For in vivo
procedures, mice were anesthetized by a single intraperitoneal
injection of 0.2 mL of a mixture of medetomidine hydrochloride
(1 mg/mL), ketamine (100 mg/mL), and sterile water in the ratio of
5:3:42 (Orion pharmaceuticals, Helsinki, Finland). Post-procedure
anesthesia was reversed by an injection of 0.2 mL of ANTISEDAN
(Pﬁzer pharmaceuticals, USA). Whenever required the pupils were
dilated using 1% tropicamide (Chauvin Pharmaceuticals, Romford,
UK). All procedures were performed under the approval of local and
national ethical and legal authorities and in accordance with the
Association for Research in Vision and Ophthalmology statements
on the care and use of animals in ophthalmic research. The study
was approved and covered by the UK Home Ofﬁce (PPL 70/1279).
2.2. In vivo imaging and quantiﬁcation of ﬂuorescent spots
As previously described (Charbel Issa et al., 2012), auto-
ﬂuorescence imaging was performed using the HRA2 confocal
scanning laser ophthalmoscope (cSLO; Heidelberg engineering,
Germany). After full dilation of the pupils, the cornea was kept
moist using ophthalmic lubricant. The 55 angle lens was used
for images acquisition and all images were acquired using the high-
resolution mode and automated real-time mode. The near-infrared
reﬂectance mode (820 nm laser) was used for alignment of the
image centrally at the optic nerve head. After focusing at the retinal
vasculature and/or nerve ﬁber layer (inner retina) the cSLO was
switched to fundus autoﬂuorescence (FAF) mode (excitation
488 nm, emission 500e700 nm). For recordings of the outer retina,
the focus was adjusted.
The images were analyzed by 2 independent masked graders,
counting the ﬂuorescent spots per image. To assess intergrader
reliability, Bland-Altman analysis was performed.
Table 1
Primers and UPL probes used for quantitative reverse transcriptase polymerase
chain reaction expression analysis
Gene Sequence UPL probe
C3 Forward CGGCAAGTTTCTGAACACAG 79
Reverse GAGTCAAAGTCTTTCAGCAGCA
Cfb Forward GCTCAACCAAATCAGTTATGAAGA 64
Reverse CGGGTTCTATTCCAGCCTTC
Cfd Forward CTGGGAGCGGCTGTATGT 79
Reverse CACGGAAGCCATGTAGGG
Properdin Forward TCTTGAGTGGCAGCTACAGG 56
Reverse CAGACCAGCCACCCATCT
Key: UPL, Universal Probe Library.
Table 2
Overview of number of animals used in different experiments of the study
Experiment Cd59a/ mice Controls
In vivo FAF quantiﬁcation 62 47
Choroidal assessment 4 4
Quantiﬁcation of ONL 6 6
ERG 6 6
qRT-PCR 5e6 5e6
Key: ERG, electroretinogram; FAF, fundus autoﬂuorescence; ONL, outer nuclear
layer; qRT-PCR, quantitative reverse transcription polymerase chain reaction.
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Flat mounts and retinal cryosections were prepared as described
before (Luhmann et al., 2012). In brief, eyes for RPE-choroidal ﬂat
mounts were ﬁxed at room temperature for 10 minutes in 4% para-
formaldehyde (PFA) before dissection and postﬁxed again in 4% PFA
and/or phosphate-buffered saline (PBS) for a total of 1 hour. Tissue
for cryosectioningwasﬁxedwith4%PFA for 1hour andwashed3 in
PBS before it was embedded in optimal cutting temperature com-
pound. Fifteen micrometerethick sections and ﬂat mounts were
blocked with PBS, 1% bovine serum albumin (Sigma-Aldrich, UK),
and 5% nonspeciﬁc goat serum (AbD Serotec, UK) including 0.3%
(cryosections) or 3% (ﬂat mounts) Triton X-100 (Sigma Aldrich) for
1 hour. The samples were incubated overnight at 4 C with a mix
of the respective antibodies including a 1:500 dilution of rabbit
anti Iba1 antibody (#019e19741, WAKO, Japan), 1:300 rat anti-GFAP
(#345860, Calbiochem), 1:200 biotinylated lectin-B4 (Sigma-
Aldrich), 1:30 phalloidin staining, (Invitrogen, UK) in the respective
blocking solution. After washing 4 times with PBS, the samples were
incubated for 2 hours at room temperature with a 1:500 dilution of
the respective AlexaFluor-conjugated secondary antibodies (Invi-
trogen-Molecular Probes, the Netherlands). The samples were
washed 4 times with PBS, counterstained with 1:1000 DAPI (40,6-
diamidino-2-phenylindole) (Invitrogen), and mounted with ﬂuo-
rescencemountingmedium (Dako FluorescenceMountingMedium,
Dako, UK). Images were obtained using a confocal laser-scanning
microscope (Leica DM5500Q, Leica Microsystems, Germany).
2.4. Characterization of choroidal microvasculature
Choroidal vasculature was visualized by adapting the protocol
described in (Saint-Geniez et al., 2009). Brieﬂy, mice were trans-
cardially perfused with 10-mL oxygenated Ringer’s solution con-
taining heparin (prewarmed to 37 C) at a rate of 2 mL/min. That
was followed by 4-mL FITC-conjugated Griffonia simplicifolia iso-
lectin B4 (0.1 mg/mL; Vector Laboratories) and 10-mL PBS, to
remove nonspeciﬁc binding. Eyes were enucleated, cornea, anterior
chamber, and retina removed and the RPE-choroidal tissue
ﬂat-mounted and incubated for 2 minutes in 0.25% trypsin (Life
Technologies, UK). Gentle brushing and pipetting was applied on
the tissue to remove the RPE cells and facilitate the visualization
and analysis of choroidal vessels. Two photographs were taken per
region of interest (center and periphery), and the area covered
by vasculature per total area of the image was determined for
quantiﬁcation using ImageJ software.
2.5. Histology and quantiﬁcation analysis of the outer nuclear layer
Eyes were enucleated and ﬁxed for 24 hours in Serra’s ﬁxative
(ethanol 96%:formaldehyde 37%:acetic acid 100% in a ratio of 6:3:1)
and were embedded in parafﬁn after dehydration in 70% and 100%
isopropanol. Sections were cut at 5 mm and stained with hema-
toxylin and eosin. Images were obtained from the central and the
peripheral region of sections containing the optic nerve.
To quantify the nuclei of the outer nuclear layer (ONL), rows of
photoreceptors were counted in 3 columns per image per eye and
the mean number of photoreceptor rows standard deviation (SD)
per section was calculated for each animal.
2.6. Electroretinogram
Electroretinograms (ERGs) were recorded from both eyes of
9-month-old Cd59a/ mice and age-matched WT controls. All
animals were dark-adapted overnight for 16 hours before ERG
recordings. The animals were prepared for ERG recordings asdescribed previously (Tan et al., 2009). ERGs were recorded using
commercially available equipment (Espion E2, Diagnosys LLC, UK).
Band-pass ﬁlter cutoff frequencies were 0.312 Hz for the low and
1000 Hz for the high frequency cutoff. Scotopic recordings were
obtained from dark-adapted animals at the following increasing
light intensities: 0.003, 0.007, 0.03, and 0.5 cd.s/m2. The recordings
consisted of 15 responses per intensity with 10-second dark-
adaptation interval between each. Final response was averaged
for each intensity. Photopic recordings were performed after 10-
minute light-adaptation intervals on a background light intensity
of 20 cd.s/m2, which was also used as the background light for
the duration of photopic recordings. Photopic ﬂash recordings
consisted of the average of 25 responses for each intensity with a
60-second light-adaptation interval between each step. Light in-
tensities used were 1, 3, 5, 10, and 20 cd.s/m2. Photopic and scotopic
b-wave amplitudes were analyzed using the Espion software
(Diagnosys LLC, UK).
2.7. Quantitative reverse transcription polymerase chain reaction
After enucleation, mouse eyes were dissected under a micro-
scope to obtain the neurosensory retina and RPE-choroid. Samples
were immediately snap-frozen in liquid nitrogen and stored until
further use at 80 C.
RNA was extracted with an RNeasy mini kit as per the manu-
facturer’s instructions (RNeasy, Qiagen, UK). RNA yield was quan-
tiﬁed on a spectrophotometer (Nanodrop 1000, Thermo Scientiﬁc,
USA). Equal quantities of 300e400 ng RNAwere used as a template
for complementary DNA (cDNA) manufacture for each sample.
cDNA was produced with a QuantiTect reverse transcriptase kit
(Qiagen, UK).
Quantitative reverse transcription polymerase chain reaction
(qRT-PCR) was performed to detect messenger RNA levels of mouse
C3,Cfb,Cfd, and Properdinusing a commercial thermal cycler (7900HT,
Applied Biosciences, USA). All reagents were obtained from Roche
Diagnostics (UK). The technique was based on FAM (ﬂuorescein
amidite)-labeled hydrolysis probes (Roche Diagnostics), and primers
were designed for speciﬁc probe-binding regions using the Roche
Universal Probe Library (Table 1). All reactions were performed in
triplicate in 20-mL reactions.
Fig. 1. Cd59a/ mice show increased age-related autoﬂuorescent fundus spots in vivo. Scanning laser ophthalmoscopy of the posterior pole of Cd59a/ (DeF) and C57BL/6 mice
(AeC). Fundus autoﬂuorescence (FAF) images show abundant autoﬂuorescent fundus spots in this extreme example of a Cd59a/mouse (F). Note the location and spread pattern of
the spots in the outer retina and/or RPE interface (F), whereas the FAF signal from the inner retina (E) and the near-infrared image (IR) (D) are unremarkable. Quantiﬁcation of
autoﬂuorescent spots (G) showed a signiﬁcant increase of spots from 4 to 15 months in both, wild type (WT) and Cd59a/, groups reﬂecting a natural age-related process with high
variation in the cohorts (*p < 0.05). However, there is a signiﬁcant difference between the genotypes (mean number of spots  standard deviation, 2-way analysis of variance with
Holm-Sidak post hoc test, p9months, 15months < 0.008, n [WT] ¼ 47, n [Cd59a/] ¼ 62).
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relative gene expression value OCt was calculated against b-actin
for each cDNA sample. OOCt values were calculated against
9-month-old WT samples (5 or 15 months, respectively when no
9 months data were generated). The assays were repeated with
retinas and RPE-choroid from at least 5 animals for each group.2.8. Statistical analysis and number of animals used
Statistical analyses were performed using GraphPad Prism 5 for
Windows (GraphPad Software Inc, USA). The average variables of
>2 groups were compared by analysis of variance (ANOVA) with
Holm-Sidak for multiple comparisons. We have included a
Fig. 2. Retinal pigment epithelium (RPE) ﬂat mounts and retinal sections identify the subretinal spots as Iba1-positive subretinal macrophages and/or microglia. To identify the
spots in Cd59a/mice, RPE ﬂat mounts (A and B) and retinal sections (C and D) were stained with IBA1 antibody (A and B green, C and D red), identifying the spots as IBA1-positive
subretinal macrophages and/or microglia that show the spread pattern, size, and apical location relative to the RPE that are consistent with the position of the autoﬂuorescent spots
observed by scanning laser ophthalmoscope in vivo. Further staining for the RPE ﬂat mounts (A and B) include phalloidin (red), DAPI (blue), and lectin (white); further staining for
the retinal sections include (C and D) GFAP (green), DAPI (blue), and lectin (white) (Scale bar C, F ¼ 25 mm). Abbreviations: WT, wild type. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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different experiments of this study (Table 2).3. Results
3.1. Increased age-related accumulation of autoﬂuorescent spots in
AF-SLO fundus images of Cd59/ mice
To detect fundus changes due to the absence of complement
regulator Cd59a, we analyzed the FAF signal by cSLO. To focus on
age-related changes, we imaged eyes of C57BL/6 WT mice (n ¼ 47,
Fig. 1AeC) and Cd59a knockout mice (n ¼ 62, Fig. 1DeF) from 3
cohorts of different age (4, 9, and 15 months). The most prominent
feature observed were autoﬂuorescent spots of the posterior pole
(Fig. 1 F), located at the outer retina and/or RPE interface.
Near-infrared images and the FAF signal of the inner retina did not
show any abnormalities in WT and Cd59a knockout mice (Fig. 1 A
and D). These spots were also observed in C57/BL6 mice and
increased with age. To quantify these changes the number of spots
per image were analyzed by 2 independent masked graders. To
assess intergrader reliability Bland-Altman analysis was performedshowing a high reliability between the graders (Bias, 3.38; SD,
13.1). Quantiﬁcation of autoﬂuorescent spots (Fig. 1G) showed a
signiﬁcant increase of spots from 4 to 15 months in both WT and
Cd59a/ groups reﬂecting a natural aging process with high
variation in the cohorts. However, the age-related accumulation of
these spots is signiﬁcantly increased in Cd59a/ mice with age
(mean number of spots  SD, 2-way ANOVA with Holm-Sidak post
hoc test, p9months, 15months < 0.008) suggesting that loss of the
complement regulator Cd59a contributes to an increase of this
fundus feature with age.3.2. Subretinal macrophages and/or microglia are the cellular
correlate of autoﬂuorescent spots in AF-SLO fundus images
Autoﬂuorescent spots in the fundus of mice are a common and
well described feature that has been linked to an accumulation of
lipofuscin loaded macrophage and/or microglia in the subretinal
space (Luhmann et al., 2009). To conﬁrm the nature of the auto-
ﬂuorescent spots in Cd59a/ mice, immunohistochemistry for the
myeloid cell marker Iba1 was performed on RPE-choroidal ﬂat
mounts and retinal cryosections (Fig. 2AeD). We identiﬁed an
Fig. 3. Retinal function and morphology of aged Cd59a/ mice seem to be not signiﬁcantly altered. Five micrometer parafﬁn sections, stained with hematoxylin and eosin (A) did
not reveal signiﬁcant qualitative changes at 4 or 15 months (scale bar A ¼ 20 mm). An analysis of the outer nuclear layer (ONL) thickness by quantiﬁcation of nuclei (B) did not show
differences between genotype or age (mean of nuclei per column þ standard deviation, n [wild type {WT}] ¼ 6, n [Cd59a/] ¼ 6). Testing of retinal function at 9 months by photopic
and scotopic electroretinogram (C) did not show any signiﬁcant abnormalities in b-wave amplitude of Cd59a/ mice compared with WT controls (mean amplitude of b-wave 
standard deviation, n [WT] ¼ 6, n [Cd59a/] ¼ 6).
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amoeboid and ramiﬁed morphology supporting these cells to be
subretinal macrophages and/or microglia. Their localization on the
apical surface of the RPE on the RPE and/or choroidal ﬂat mount
(Fig. 2A and B) and in retinal sections (Fig. 2C and D) of WT and
Cd59a-deﬁcient mice, respectively correlated well with the spread
pattern, size, and location of the autoﬂuorescent spots observed
in vivo in the autoﬂuorescence scanning laser ophthalmoscopy
(AF-SLO) fundus images of Cd59a/ mice and thereby conﬁrming
the subretinal macrophages and/or microglia to be the cellular
correlate of these autoﬂuorescent spots.3.3. Cd59a deﬁcient and WT mice show similar retinal structure
and function during aging
To assesswhether the Cd59adeﬁciency leads to structural changes
in retinal morphology, we prepared 5-mm parafﬁn sections and
stainedwith hematoxylin and eosin (Fig 3A). A qualitative analysis did
not reveal signiﬁcant changes at 4 or 15 months. To quantify changes
of the ONL we analyzed ONL thickness by quantiﬁcation of nuclei per
column (Fig. 3B) in 4- and 15-month-old animals (average of 3 counts
per eye; n [WT]¼ 6, n [Cd59a/]¼ 6). This did not showa signiﬁcant
difference between genotype and age. To assess changes in retinalfunctions, we performed scotopic and photopic ERG at 4 (data not
shown) and 9 months (Fig. 3C). This did not reveal any signiﬁcant
abnormalities in b-wave amplitude of Cd59a/ mice compared with
WT controls (n [WT] ¼ 6, n [Cd59a/] ¼ 6).3.4. Choroidal assessment of Cd59a/ mice does not show a
signiﬁcant difference to WT mice in vasculature
To analyze whether deﬁciency of Cd59a may lead to age-related
changes in the choriocapillaris, the microvasculature closest to the
basal side of the RPE and the accumulating macrophages and/or
microglia, we performed perfusions with FITC-conjugated isolectin
B4 and trypsin digests of RPE and/or choroidal ﬂatmounts on 9- to
10-month-old Cd59a/ and age-matched WT littermate controls
(Fig. 4AeC). Thequalitative analysis of FITC-labeled choriocapillaris did
not reveal signiﬁcant changes in its morphology (Fig. 4A vs. B). In
addition, the quantiﬁcation of the percentage area covered by this
microvasculature relative to the total image area in the central and the
periphery of the RPE-choroidal ﬂat mount did not show signiﬁcant
differences. This suggests that in the absence of Cd59a also the
morphologyof the choriocapillaris iswellmaintainedwith age, at least
up to 9e10 months of age (Fig. 4AeC, n [WT] ¼ 4, n [Cd59a/] ¼ 4).
Fig. 4. Assessment of choroidal vasculature of Cd59a/mice does not show signiﬁcant
changes in choriocapillaris. FITC lectin perfused retinal pigment epithelium (RPE)-
choroidal ﬂatmounts that were trypsin-digested to remove the RPE allow visualization
of the choriocapillaris beneath the RPE. By comparing 9- to 10-month-old Cd59a/ (B)
mice and age-matched littermate wild-type (WT) controls (A), we did not observe any
qualitative abnormalities in the choroidal vasculature, and also quantiﬁcation of the
percentage of the area covered by the choriocapillaris (C) did not reveal signiﬁcant
changes due to the Cd59a knockout (n per group ¼ 4).
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in the RPE-choroid of senescent Cd59a/ mice with less
pronounced changes in the neuroretina
To analyze the effects of complement regulator Cd59a deﬁciency
on the local expression of main factors of the alternative pathway,
we performed qRT-PCR on ocular tissue samples from 4-, 9-, and
15-month-old WT and Cd59a/mice (number of mice per age and
genotype ¼ 5e6). The eyes were dissected into neuroretina and
RPE-choroid complex, allowing separate analysis of these 2 com-
partments. We performed qRT-PCR for expression of complement
component 3 (C3), complement factor B (Cfb), Cfd, and Properdin.
In the RPE-choroid samples (Fig. 5), we observed a signiﬁcant
age-related increase in all analyzed complement genes in WT and
Cd59a/ mice. For C3, Cfb, and Cfd, but not Properdin, this increase
was signiﬁcantly more pronounced in the Cd59a / mice (2-way
ANOVA). C3 expression at 4 months was very low in both, WT
and Cd59a/ mice (WT: Cd59a/ ratio 1:0.8) but increased about
29-fold in the WT by 9 months of age (Fig. 5). The increase in local
C3 expression from 4 to 9 months was even more pronounced in
Cd59a/ mice. By the age of 9 months, C3 expression in Cd59a/
mice was more than twice as high as in WT mice (WT:Cd59a/
ratio 1:2.2). By 15 months, the local C3 expression in WT samples
increased by 5-fold compared with the 9-month-old samples
and to 25-fold in the Cd59a/ cohort (WT:Cd59a/ ratio 1:5.2)
(pC3 < 0.0001).
A similar expression pattern over age can be observed with local
Cfb expression. Here, already at an age of 4 months a difference
between genotypes can be observed (WT:Cd59a/ ratio at
4 months 1:5.2). With age there is a signiﬁcant increase in relative
expression of local Cfb, but the ratio between the genotypes stays
relatively stable (WT:Cd59a/ ratio at 9 months 1:5.4 and at
15 months 1:5.9) (pCfb < 0.0001). Local Cfd expression also shows asimilar pattern. However, local expression of this complement
factor is very low and detection at early time points was difﬁcult. At
4 months the Cd59a/ samples already expressed 5.2 times more
Cfd thanWT. The WT Cfd expression increased from 4 to 15 months
by 4-fold. Most interestingly, local Cfd expression in 15-month-old
Cd59a/ mice, although variable, was generally very high
compared with WT mice (WT:Cd59a/ ratio at 15 months 1:16.3;
pCfd< 0.02). The local expression of Properdin had a different proﬁle
than the other examined genes. There is a signiﬁcant increase of
local Properdin expression from 4 and 9e15 months, but there is
no difference between WT and Cd59a/ mice (WT:Cd59a/ ratio
at 4 months 1:1.5; at 9 months 1:1.5; and at 15 months 1:0.9)
(pProperdin < 0.002).
In the neuroretinal samples, overall the relative change in
expression of complement genes with age were very small
compared to that in the RPE choroid, as is immediately visible by
the different scales of the axes in Figs. 5 and 6. However, we still
detected signiﬁcant changes with age in the retinal expression
levels of Cfd and Properdin but not C3 and Cfb which nevertheless
both showed a variable trend toward increased expression in
Cd59a/ mice at 15 months (WT:Cd59a/ ratio at 15 months for
C3 1:3.6 and for Cfb 1:2.3). Retinal Cfd levels were very low and
could only be detected reliably at 15 months when there was a
signiﬁcant increase in Cd59a/mice (t test p < 0.04; WT:Cd59a/
ratio 1:6.3). Properdin expression in the neuroretina increases with
age from 9 to 15months-by a factor of 12 inWTmice and a factor of
7 in the Cd59a/ animals. Although the WT:Cd59a/ ratio at
9 months was equivalent in both (1:1.1), the detected difference in
the age-related increase resulted in a signiﬁcant but small decrease
of Properdin expression at 15 months in Cd59a/ mice compared
with WT animals (WT:Cd59a/ ratio at 15 months 1:0.65). This
observation did not follow the trend of the other genes (pProperdin <
0.0001) but should be interpreted with care because relative
expression changes below 2-fold change may be at the limit of
detection for a relative quantiﬁcation RT-PCR method. Overall,
these expression analyses revealed that the combination of age and
Cd59a deﬁciency leads to a preferential expression increase of
complement genes in the RPE-choroid, while the neuroretina
shows rather minor expression changes in these genes.
3.6. Enhanced moderate light exposure for 7 days does not alter
local expression of complement genes in Cd59a deﬁcient mice on a
C57Bl/6 background
To analyze the effects of the combination of Cd59a deﬁciency
with moderate light exposure as an additional potential trigger for
accelerated complement dysregulation, we exposed 5-month-old
Cd59a/ mice and age-matched littermate WT controls to 7 days
constant 1000 lux white light and compared them to age-matched
controls in normal housing conditions. In previous experiments, we
have shown that this light exposure regime can induce the local
activation of complement factor expression in Balb/c mice, (article
in preparation). qRT-PCR of main components of the alternative
complement pathway (Fig. 7) did not show signiﬁcant changes in
gene expression of C3, Cfb, Cfd, and Properdin after light exposure in
either group of animals. (2-way ANOVA with Holm-Sidak post hoc
test; n per group ¼ 5e6).
4. Discussion
Our data suggests that Cd59a contributes to a tight control of the
immune homeostasis of the eye and that it is particularly important
for the maintenance of the immune homeostasis of the RPE-
choroidal complex during aging. This is indicated by the observa-
tion that Cd59a/ mice show signiﬁcantly increased accumulation
Fig. 5. Increased expression of complement activators on the RPE and/or choroid of Cd59a/ mice with age. Age- and genotype-related effects were generally more pronounced in
the RPE and/or choroid complex showing signiﬁcant age-related changes in all tested complement genes. C3, Cfb, and Cfd also showed signiﬁcant changes between the genotype
whereas Properdin showed a signiﬁcant change with age, irrelevant of the genotype. (fold change to 9-month-old WT þ standard deviation, 2-way analysis of variance with Holm-
Sidak post hoc test, pC3,Cfb < 0.0001, pCfd < 0.02, pProperdin < 0.002, n per age and genotype ¼ 5e6, n.d.¼ not detectable or below threshold). Abbreviations: RPE, retinal pigment
epithelium; qRT-PCR, quantitative reverse transcription polymerase chain reaction; WT, wild type.
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process compared with age-matched WT animals and further
supported by the preferential increase of the expression of the
complement activators C3, Cfb, and Cfd in the RPE-choroidal
complex during aging that was further increased in Cd59a/mice.
4.1. Subretinal macrophages and/or microglia accumulation
suggests an innate immune activation in the eye of Cd59a/ mice
during aging
Accumulation of macrophage and/or microglia in the subretinal
space has been described in WT mice as a typical feature of
age-related processes and represents a normal parainﬂammatory
response of the cellular innate immune system to age-related tissue
changes to maintain retinal homeostasis (Luhmann et al., 2009; Xu
et al., 2009). The fact that Cd59a/ mice show an increase in the
accumulation of these cells and a far higher variability in this
feature with age than WT mice supports that Cd59a plays a role in
controlling the ocular innate immune homeostasis. However, also
in WT mice the accumulation of the subretinal cells not only
increases but also becomes more varied with age indicating that
additional alterations in other immune regulatory pathways, such
as, for example, the chemokine signaling pathways via Ccl2 or
Cx3cl1 (Luhmann et al., 2009; Raoul et al., 2008), may also be
involved in the observed shift of immune homeostasis. However,there has been some controversy about the origin of these cells,
with some investigators referring to them as subretinal macro-
phages, implying that they have moved into the subretinal space
from the circulation, and some investigators referring to them as
activated microglia, implying that these cells have migrated from
the inner retina toward the RPE. Recent evidence suggests that both
could be true and that these subretinal cells represent a mix of both
myeloid cell populations (Sennlaub et al., 2013), indicating an
altered innate immune status in the retina of Cd59a/ mice.
4.2. The RPE-choroid of Cd59a/ mice is particular vulnerable to
complement dysregulation with age
The local expression of complement factors by the RPE and
neurosensory retina has been well described in humans (Anderson
et al., 2002), mice (Chen H. et al., 2008, Chen et al., 2008, 2010; Luo
et al., 2011), and in vitro cell culture (Chen et al., 2008; Luo et al.,
2011). It is also known that there is an increase of local expres-
sion with age (Chen H. et al., 2008, Chen et al., 2008, 2010). In
mouse, the complement regulator Cd59a is strongly expressed in
the neurosensory retina and to a lesser extent the RPE. There also
seems to be stronger expression in themouse eye than in nonocular
tissues (Faber et al., 2012; Yang et al., 2009) which highlights the
relevance of Cd59a for the eye. It has also been described that the
expression of Cd59a increases in the neuroretina with age, whereas
Fig. 6. Only minor changes of complement expression in the neuroretina of Cd59a/ mice with age. C3 and Cfb only show a trend toward increased expression in 15-month-old
Cd59a/ mice, whereas Cfd is signiﬁcantly elevated at that time point but shows generally very low expression in the retina (9 months below threshold). Properdin expression
increases signiﬁcantly with age but does not show a signiﬁcant difference between the genotype (fold change to 9-month-old WT þ standard deviation, Cfd: t test p < 0.04, all other:
2-way analysis of variance with Holm-Sidak post hoc test, pProperdin < 0.0001, n per age and genotype ¼ 5e6, n.d. ¼ not detectable or below threshold). Abbreviations: qRT-PCR,
quantitative reverse transcription polymerase chain reaction; WT, wild type.
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et al., 2012). In our study, however, the genetic ablation of
the membrane-bound complement regulator Cd59a caused a
preferential increase of C3, Cfb, and Cfd expression with age in the
RPE-choroid of Cd59a/ mice relative to that observed during
aging in WT mice. In contrast, in the neuroretina, the overall
relative expression changes were much smaller than those in the
RPE-choroid and only a trend for increased C3 and Cfb expression
with age and Cd59a/ genotype was observed suggesting that in
particular the RPE-choroidal complex, and only to a lower degree
the retina, is affected by the localized complement dysregulation
due to Cd59a deﬁciency during aging. Such a preferential change in
expression of inﬂammatory genes in the RPE-choroidal complex
with age is consistent with a previous microarray study inWTmice
showing the preferential increase of many inﬂammatory genes in
the RPE-choroid with age (Chen H. et al., 2008). In contrast to the 3
other activators for the alternative complement pathway, Properdin
showed a signiﬁcant age-related increase in both RPE-choroid and
retina that was not prominently affected by the Cd59a deﬁciency
suggesting that its expression may be independently regulated
during aging.
Our study design does not distinguish speciﬁc cell types that
may be responsible for the observed upregulation of complement
genes. Currently, there is no available immunohistochemistry-
based marker that can distinguish the origin of macrophages andmicroglia cells. Both RPE and microglia and/or macrophages have
been described as relevant sources of complement expression that
increases with age (Luo et al., 2011) and might be both relevant in
subretinal accumulation (Sennlaub et al., 2013). However, the
relative contribution may depend on the degree and nature of the
inﬂammatory stimulus that leads to their activation. Macrophage
and/or microglia might be important cellular sources of local
complement expression in the eye (Ma et al., 2013) and among
them in particular inﬁltrating subretinal macrophages have been
shown to produce C3 after acute light exposure (Rutar et al., 2011).
The latter may be a major source of the observed increase in
expression of C3, Cfb, and Cfd in the RPE-choroidal samples because
the increase in expression of these factors seems to correspond to
an increase in these cells in the fundus. However, we cannot
exclude that resident myeloid cells in the RPE-choroid may also
contribute signiﬁcantly, similarly to retinal microglia, which have
been shown to upregulate these complement factors with age (Ma
et al., 2013). Properdin may possibly be derived from neutrophils
that have been suggested as a major source of this activator of the
alternative complement pathway during innate immune responses
(Camous et al., 2011). In addition, the interplay of macrophages
and/or microglia and RPE might be relevant. It has been shown that
RPE-expression of complement factors can be regulated by different
activation states of macrophages. In vitro experiments showed that
RPE cells, after exposure to conditionedmedium frommacrophages
Fig. 7. Elevated constant light exposure of 5-month-old Cd59a/ mice does not show signiﬁcant changes in complement activator expression. Five-month-old Cd59a/ and WT
mice in normal housing conditions and after constant 7 days 1000 lux light exposure were analyzed by qRT-PCR. No signiﬁcant upregulation after light exposure was observed (fold
change to WT in normal housing conditions þ standard deviation, 2-way analysis of variance with Holm-Sidak post hoc test; n per group ¼ 5e6). Abbreviations: RPE, retinal
pigment epithelium; qRT-PCR, quantitative reverse transcription polymerase chain reaction; WT, wild type.
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lation of complement factors, for instancewith a 30-fold increase in
Cfb and C3 expression (Luo et al., 2013). These ﬁnding suggest that
both resident and recruited myeloid cells and RPE cells may
contribute to local activation of the alternative complement
pathway, either by opsonization or other mediators that may
further stimulate cellular components of the immune system and
thereby generate an activation loop between the humoral and
cellular innate immune system that may propel local changes.
4.3. Cd59a-mediated innate immune dysregulation is not sufﬁcient
to cause retinal degeneration
Despite clear evidence for an increasing overactivation of the
innate immune system in the ocular tissues of Cd59a/ mice, we
have not found any signiﬁcant histological or functional differences
in the retina of young and aged Cd59a/ mice compared with
age-matched WT controls. Even at 15 months there was no signif-
icant difference in retinal histology or outer nuclear layer thickness
suggesting that Cd59a deﬁciency alone is not sufﬁcient to cause
retinal degeneration or dysfunction with age. Furthermore, quali-
tative and quantitative analysis of the choriocapillaris did not show
a signiﬁcant difference in the Cd59a knockout mice. The preferen-
tial molecular changes in the RPE-choroid seem inconsistent with
the reported higher expression level of Cd59a in the neurosensory
retina and its increase with age (Faber et al., 2012), but may be
consistent with the idea that a major source of complement
proteins is derived from the systemic circulation (Anderson et al.,
2010). Our observation may thus highlight the differences in thecontrol of the immune status between the 2 ocular compartments,
on one hand the neuroretina as a part of the central nervous system
and on the other hand the RPE-choroid with its strong inﬂuences
from the systemic circulation. Furthermore, the lack of manife-
station of any obvious retinal pathology in this study may be in line
with the general perception that Cd59a deﬁciency represents only
one of many factors that may control the immune homeostasis in
the aging retina and RPE-choroid. It could, for example, be that in
the context of Cd59a deﬁciency in mice additional factors and
triggers are required to induce enhanced retinal pathology that
wouldmanifest in RPE damage or photoreceptor loss with age. Such
additional factors could be an altered expression of complement
regulators during the course of AMD, an idea that was supported by
recent studies on human AMD eyes (Ebrahimi et al., 2013) or by
the observation that several risk conveying polymorphisms in
complement genes for AMD inﬂuence the activation of the C3
convertase synergistically (Heurich et al., 2011). However, the
interspecies differences of the complement system in human and
mice need to be considered. Mice have 2 homologue Cd59 genes.
They also have additional cell bound regulators, most notably Crry,
that could possibly compensate for Cd59a absence. Thus, it could,
for example, be that in the context of Cd59a deﬁciency in mice, an
additional loss of the murine homologue Cd59b (Donev et al., 2008)
are required to induce enhanced retinal pathology that would
manifest in RPE damage or photoreceptor loss with age. Enhanced
local stress or additional triggers for innate immune activation,
such as photo-oxidative protein adducts in the retina (Weismann
et al., 2011), may also increase local complement dysregulation
and ocular pathology. However, moderately-enhanced constant
P. Herrmann et al. / Neurobiology of Aging 36 (2015) 2637e2648 2647light for 7 days in combinationwith Cd59a deﬁciency did not result
in a signiﬁcantly enhanced complement dysregulation in either of
the 2 ocular compartments. This suggests that Cd59a deﬁciency, at
least in the context of the C57Bl/6 genetic background, which is
more resilient to light (Ng and Streilein, 2001), is not sufﬁcient to
cause an enhanced local complement dysregulation in response
to this light trigger, that in Balb/c mice initiates enhanced local
complement activation and ocular pathology (unpublished obser-
vations, manuscript in preparation).
4.4. The potential role of altered complement regulator expression
in the RPE-choroidal complex in the pathology of AMD
Overall, it is difﬁcult to estimate the effects of local complement
expression on age-related pathology such as AMD. The total locally-
produced amount of complement factor proteins might be quite
irrelevant compared with the abundant amount derived from the
plasma. However, the speciﬁc local increase in secretion of com-
plement factors, for example, by recruited myeloid or local RPE
cells, in proximity to complex barriers such as Bruch’s membrane
and the inner blood-retinal barrier may drive activation of the
complement system and thereby local pathology. It may be that the
relatively lower Cd59a RNA levels in the RPE-choroid together with
the higher level of complement expression with age simply reﬂects
the incapability of this “peripheral” tissue compartment to main-
tain immune homeostasis with age, whereas in the neuroretina
in addition to the higher Cd59a expression also other immune
suppressive mechanisms may be in place that maintain the im-
mune homeostasis in the central nervous system. Recent evidence
may support the idea that macrophages and microglia maybe the
source of expression of C3 and CFB (Rutar et al., 2011) and thus it
maybe that resident macrophages in the choroid can more actively
respond to the age-related changes in the tissue, whereas their
activation is suppressed in the retina.
Altered polarity of protein secretion pathways during aging
might also be important in this respect, which is supported by the
observation that Cfb secretion from the RPE occurs only apically in
young mice but shifts toward a basal secretion in aged mice
(Chen et al., 2008). Evidence for such local alterations in the
expression of the complement regulator CD59 in AMD pathology in
humans comes from a recent study that showed strong CD59
protein expression in the macular RPE and the subretinal space of
early AMD patients compared with healthy subjects. In more
advanced forms of AMDwith altered RPEmorphology, however, the
CD59 expression was reduced (Ebrahimi et al., 2013). It was
therefore proposed that the initial upregulation of CD59 in
response to early inﬂammationwould be protective, while the later
reduction in CD59 levels may be associated with disease pathology.
Consistent with this idea, another in vitro experiment on primary
human RPE cells showed an upregulation of expression of com-
plement regulators, including CD59, in response to inﬂammatory
cytokines (Yang et al., 2009). Similarly, the reduction of local CFH
expression in the choriocapillaris and Bruch’s membrane of AMD
donor eyes (Bhutto et al., 2011) also suggested that a reduction of
local complement regulator expression might be associated with
AMD pathogenesis. Our study, however, only in part supports this
idea. Although we observed a preferential expression in local acti-
vators of the alternative complement pathway in the RPE-choroid
as a consequence of the genetic ablation of the terminal comple-
ment pathway regulator Cd59a, we have not found any clear
evidence for associated ocular pathology in these mice.
Our data, therefore, support a role of Cd59a in controlling the
innate immune status of the RPE-choroidal complex and empha-
sizes the particular vulnerability of this ocular compartment to the
dysregulation of alternative complement pathway during aging.Disclosure statement
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